BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18089599)

  • 1. Type-specific antiviral antibodies to genital human papillomavirus types in mothers and newborns.
    Heim K; Hudelist G; Geier A; Szedenik H; Christensen ND; Concin N; Bergant A; Volgger B; Czerwenka K; Höpfl R
    Reprod Sci; 2007 Dec; 14(8):806-14. PubMed ID: 18089599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
    Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
    J Infect Dis; 2000 Jun; 181(6):1911-9. PubMed ID: 10837170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata.
    Kawana K; Yasugi T; Yoshikawa H; Kawana Y; Matsumoto K; Nakagawa S; Onda T; Kikuchi A; Fujii T; Kanda T; Taketani Y
    Am J Perinatol; 2003 Jan; 20(1):11-6. PubMed ID: 12638076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries.
    Santamaria H; Manoutcharian K; Rocha L; Gonzalez E; Acero G; Govezensky T; Uribe LI; Olguin A; Paniagua J; Gevorkian G
    Clin Immunol; 2001 Dec; 101(3):296-302. PubMed ID: 11726222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.
    Ho GY; Studentsov Y; Hall CB; Bierman R; Beardsley L; Lempa M; Burk RD
    J Infect Dis; 2002 Sep; 186(6):737-42. PubMed ID: 12198606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of herpes simplex virus 1 and 2 (HSV-1 and HSV-2) IgG and IgM by ELISA in cord blood and sera of mothers with pregnancy complications].
    Cengiz L; Kiyan M; Cengiz AT; Kara F; Uğurel MS
    Mikrobiyol Bul; 1993 Oct; 27(4):299-307. PubMed ID: 8264443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls.
    Cubie HA; Plumstead M; Zhang W; de Jesus O; Duncan LA; Stanley MA
    J Med Virol; 1998 Nov; 56(3):210-6. PubMed ID: 9783687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.
    Dias D; Van Doren J; Schlottmann S; Kelly S; Puchalski D; Ruiz W; Boerckel P; Kessler J; Antonello JM; Green T; Brown M; Smith J; Chirmule N; Barr E; Jansen KU; Esser MT
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):959-69. PubMed ID: 16085914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
    Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients.
    Lewensohn-Fuchs I; Ljungman P; Kjerrström A; Ringdén O; Dalianis T
    Bone Marrow Transplant; 1996 Aug; 18(2):333-7. PubMed ID: 8864443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
    Ghim S; Newsome J; Bell J; Sundberg JP; Schlegel R; Jenson AB
    Exp Mol Pathol; 2000 Jun; 68(3):147-51. PubMed ID: 10816383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HPV types and neutralizing antibodies in Gansu province, China.
    Wu X; Zhang C; Feng S; Liu C; Li Y; Yang Y; Gao J; Li H; Meng S; Li L; Zhang Y; Hu X; Wu X; Lin L; Li X; Wang Y
    J Med Virol; 2009 Apr; 81(4):693-702. PubMed ID: 19235880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis.
    Maloney EM; Unger ER; Tucker RA; Swan D; Karem K; Todd NW; Reeves WC
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):711-5. PubMed ID: 16847177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission.
    Smith EM; Ritchie JM; Yankowitz J; Swarnavel S; Wang D; Haugen TH; Turek LP
    Sex Transm Dis; 2004 Jan; 31(1):57-62. PubMed ID: 14695959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of antibodies against E4 and E7 from human papillomavirus type 16 in Mexican soldiers.
    Plett-Torres T; Cruz-Valdez A; Esquivel-Guadarrama F; Hernández-Nevarez P; Lazcano-Ponce E; Gutiérrez-Xicotencatl L
    Arch Virol; 2007 Jan; 152(1):97-114. PubMed ID: 16896549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus antibodies in young female subjects in England.
    Jit M; Vyse A; Borrow R; Pebody R; Soldan K; Miller E
    Br J Cancer; 2007 Oct; 97(7):989-91. PubMed ID: 17726462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.